Related references
Note: Only part of the references are listed.Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial
Menno R. van den Bergh et al.
CLINICAL INFECTIOUS DISEASES (2013)
Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial
Kerry-Ann F. O'Grady et al.
TRIALS (2013)
Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol
Roman Prymula et al.
VACCINE (2013)
Molecular Surveillance of True Nontypeable Haemophilus influenzae: An Evaluation of PCR Screening Assays
Michael J. Binks et al.
PLOS ONE (2012)
Respiratory Bacterial Pathogens in the Nasopharynx and Lower Airways of Australian Indigenous Children with Bronchiectasis
Kim M. Hare et al.
JOURNAL OF PEDIATRICS (2010)
Phylogeographic reconstruction of a bacterial species with high levels of lateral gene transfer
Talima Pearson et al.
BMC BIOLOGY (2009)
Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian aboriginal children with recently treated chronic suppurative otitis media - A randomized controlled trial
Amanda Leach et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Measuring nasal bacterial load and its association with otitis media
Heidi Smith-Vaughan et al.
BMC EAR NOSE AND THROAT DISORDERS (2006)
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae:: a randomised double-blind efficacy study
R Prymula et al.
LANCET (2006)
Share Paper
